Medicare covers deep brain stimulation (DBS) for eligible people diagnosed with essential tremors or idiopathic Parkinson’s disease to help reduce tremors and improve daily activities. To qualify for ...

There is still no cure for Parkinson’s disease, but the U.S. Food and Drug Administration (FDA) approved a new deep brain stimulator that could benefit patients with the motor condition. On Feb 24, ...

Electricity is the brain’s language. For a decade, National Institutes of Health (NIH) funding and philanthropy have enabled UC San Francisco physician-scientists to decipher this language and use ...

Subthalamic nucleus deep brain stimulation (STN-DBS) provides lasting benefits for patients with moderate-to-advanced Parkinson’s disease (PD), with sustained improvements in movement and quality of ...

Shortly after obtaining a greenlight in Europe and after more than 10 years in development, Medtronic has now received the FDA’s approval for its adaptive, closed-loop neurostimulation approach to ...

Deep brain stimulation is a surgical brain therapy used to treat symptoms of movement disorders such as dystonia, Parkinson’s disease and epilepsy. Performing over 100 DBS procedures annually, the ...

Swedish neurotech startup Flow Neuroscience has secured FDA approval for the first brain stimulation device for home use in ...

An early-stage clinical trial has shown that deep brain stimulation (DBS) applied to the cerebellum may aid the recovery of upper limb function after stroke. Researchers studied 12 people with ...

The field of epilepsy research has rapidly evolved with an appreciation that seizures arise from dysfunctions in distributed ...

While stuttering was believed to have purely psychological causes up until about 30 years ago, scientists today attribute it to a variety of factors capable of contributing to its development. For ...